HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yan Feng Selected Research

human MIRN29a microRNA

2/2020Overexpression of miR-17 is correlated with liver metastasis in colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yan Feng Research Topics

Disease

116Neoplasms (Cancer)
06/2022 - 07/2002
30Inflammation (Inflammations)
08/2022 - 10/2006
26Infections
03/2022 - 02/2006
22Neoplasm Metastasis (Metastasis)
09/2021 - 01/2012
19Sepsis (Septicemia)
03/2022 - 05/2010
17Carcinogenesis
01/2022 - 09/2003
14Breast Neoplasms (Breast Cancer)
01/2022 - 02/2007
14Lung Neoplasms (Lung Cancer)
02/2021 - 11/2010
13Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2022 - 05/2013
10Carcinoma (Carcinomatosis)
01/2022 - 11/2011
9Asthma (Bronchial Asthma)
01/2021 - 03/2005
9Melanoma (Melanoma, Malignant)
01/2020 - 07/2013
8Brain Edema (Cerebral Edema)
04/2022 - 07/2013
8Colorectal Neoplasms (Colorectal Cancer)
03/2022 - 10/2017
8Ischemic Stroke
01/2022 - 05/2011
8Ischemia
06/2021 - 10/2010
8Body Weight (Weight, Body)
03/2021 - 07/2014
8Adenocarcinoma of Lung
11/2020 - 12/2013
8Glioma (Gliomas)
01/2020 - 11/2012
7Hypertension (High Blood Pressure)
01/2022 - 06/2004
7Gestational Diabetes (Gestational Diabetes Mellitus)
01/2022 - 01/2020
7Stomach Neoplasms (Stomach Cancer)
01/2022 - 08/2011
7Insulin Resistance
08/2021 - 11/2006
7Neurodegenerative Diseases (Neurodegenerative Disease)
01/2019 - 03/2010
7Traumatic Brain Injuries (Traumatic Brain Injury)
06/2018 - 04/2016
7Measles
01/2018 - 08/2009
6Wounds and Injuries (Trauma)
04/2022 - 05/2015
6Hepatocellular Carcinoma (Hepatoma)
01/2022 - 07/2003
6Necrosis
01/2022 - 12/2002
6Pain (Aches)
05/2021 - 08/2012
6Reperfusion Injury
01/2020 - 03/2011
6Infarction (Infarctions)
01/2019 - 04/2012
5Nasopharyngeal Carcinoma
06/2022 - 09/2004
5Gastritis
01/2022 - 08/2011
5Liver Neoplasms (Liver Cancer)
01/2022 - 07/2003
5Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2022 - 01/2017
5Lymphatic Metastasis
09/2021 - 02/2007
5Hyperglycemia
08/2021 - 06/2012
5Hypoxia (Hypoxemia)
05/2021 - 01/2014
5Stroke (Strokes)
01/2021 - 09/2013
5Brain Ischemia (Cerebral Ischemia)
01/2020 - 07/2013
5Squamous Cell Carcinoma of Head and Neck
11/2019 - 06/2009
5Type 2 Diabetes Mellitus (MODY)
10/2018 - 08/2011
5Triple Negative Breast Neoplasms
01/2018 - 01/2013
5Human Influenza (Influenza)
05/2017 - 01/2011
4B-Cell Lymphoma (Lymphoma, B Cell)
11/2022 - 01/2019
4Pneumonia (Pneumonitis)
08/2022 - 01/2015
4Mitochondrial Diseases (Mitochondrial Disease)
04/2022 - 12/2014
4Brain Injuries (Brain Injury)
04/2022 - 01/2017
4Lymphoma (Lymphomas)
01/2022 - 12/2009
4Colonic Neoplasms (Colon Cancer)
12/2021 - 09/2003

Drug/Important Bio-Agent (IBA)

49Proteins (Proteins, Gene)FDA Link
03/2022 - 10/2006
25CytokinesIBA
08/2022 - 09/2003
23Messenger RNA (mRNA)IBA
01/2020 - 08/2007
19Pharmaceutical PreparationsIBA
06/2022 - 05/2008
19Biomarkers (Surrogate Marker)IBA
01/2022 - 12/2013
19MicroRNAs (MicroRNA)IBA
01/2022 - 06/2012
11RNA (Ribonucleic Acid)IBA
01/2022 - 08/2007
11DNA (Deoxyribonucleic Acid)IBA
01/2022 - 07/2003
11Glucose (Dextrose)FDA LinkGeneric
01/2021 - 01/2008
10NivolumabIBA
01/2022 - 01/2016
10EnzymesIBA
01/2020 - 03/2009
8Biological ProductsIBA
01/2019 - 02/2014
7CholesterolIBA
03/2022 - 11/2006
6Reactive Oxygen Species (Oxygen Radicals)IBA
11/2022 - 12/2013
6Matrix Metalloproteinases (MMPs)IBA
11/2022 - 01/2016
6Particulate MatterIBA
08/2022 - 01/2016
6LipidsIBA
03/2022 - 01/2006
6CateninsIBA
01/2022 - 05/2011
6Hormones (Hormone)IBA
08/2021 - 06/2016
6Immunoglobulin G (IgG)IBA
01/2021 - 01/2012
6IpilimumabIBA
01/2021 - 07/2013
6LigandsIBA
11/2019 - 06/2011
6salicylhydroxamic acid (SHAM)IBA
12/2017 - 08/2011
6Toll-Like Receptor 4IBA
11/2017 - 03/2011
5cytolethal distending toxinIBA
03/2022 - 06/2005
5colibactinIBA
03/2022 - 12/2016
5Conditioned Culture MediaIBA
01/2022 - 01/2021
5Interleukin-6 (Interleukin 6)IBA
03/2021 - 08/2007
5Long Noncoding RNAIBA
11/2020 - 09/2018
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2018 - 02/2007
5Toll-Like Receptor 2IBA
10/2016 - 05/2010
5Triglycerides (Triacylglycerol)IBA
04/2015 - 11/2006
4Estrogen ReceptorsIBA
08/2022 - 02/2007
4Interleukin-17 (Interleukin 17)IBA
01/2022 - 01/2015
4Insulin (Novolin)FDA Link
01/2022 - 01/2008
4Therapeutic UsesIBA
01/2022 - 03/2005
4Phosphopyruvate Hydratase (Enolase)IBA
01/2022 - 08/2020
4AntibodiesIBA
12/2021 - 12/2011
4AntigensIBA
11/2021 - 01/2012
4Phenobarbital (Luminal)FDA Link
03/2021 - 04/2006

Therapy/Procedure

48Therapeutics
06/2022 - 07/2003
17Radiotherapy
06/2022 - 09/2004
16Drug Therapy (Chemotherapy)
03/2022 - 01/2011
13Punctures
01/2022 - 05/2010
11Ligation
01/2019 - 05/2010
6Intraperitoneal Injections
01/2021 - 07/2013
5Neoadjuvant Therapy
12/2021 - 01/2018
5Mastectomy (Mammectomy)
07/2019 - 10/2009
4Anesthesia
05/2021 - 01/2012